<DOC>
	<DOC>NCT01455415</DOC>
	<brief_summary>This study is to test the effectiveness of pregabalin in treating nerve pain caused by diabetes. The suitable subjects will be patients who also use an non-steroid anti-inflammatory drug for another pain which is not related to the diabetic nerve pain.</brief_summary>
	<brief_title>Effect Of Pregabalin Treatment In Patients With Diabetic Nerve Pain Who Currently Use A Non-Steroid Anti-Inflammatory Drug (NSAID) For Another Pain</brief_title>
	<detailed_description />
	<mesh_term>Pain</mesh_term>
	<mesh_term>Peripheral Nervous System Diseases</mesh_term>
	<mesh_term>Diabetic Neuropathies</mesh_term>
	<mesh_term>Pregabalin</mesh_term>
	<criteria>Type 1 or 2 diabetes with painful neuropathy Currently treated with one NSAID (including COX 2 inhibitors) for a co morbid pain condition with a regular dose Meet predefined level of pain severity at entrance History of failed pregabalin treatment due to lack of efficacy at therapeutic dose Participated in a previous or ongoing pregabalin clinical trial Neurologic disorders unrelated to diabetic neuropathy that may confound the assessment of distal neuropathic pain</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
</DOC>